The causes of diarrhoea on Wegovy arent fully understood
metformin for women with PCOS A 2017 randomized controlled trial comparing metformin to a GLP-1 agonist found that obese women with PCOS who took the GLP-1 agonist lost an additional 2 kg (4.4 lbs), had more frequent menstrual cycles, and had a higher rate of achieving pregnancy (43.6% vs
The reduction in body weight has been associated with improvements in insulin sensitivity, blood pressure, lipid profiles, and inflammatory markers, highlighting the broad spectrum of benefits conferred by weight loss
The breakdown provided helps you understand the cost over time
Learning how GLP-1s affect your digestion is the first step toward making your treatment as comfortable as possible
The enhanced potency is due to the decreased binding of IGF1 LR3 to all known IGF binding proteins